Nichirei Corporation (2871.T) Bundle
Explore Nichirei Corporation's financial profile through hard numbers: net sales reached ¥702.08 billion for the fiscal year ending March 31, 2025 (TTM ¥702.58 billion as of Sept 30, 2025) with Q1 FY2026 sales of ¥170.8 billion and revenue per employee of ¥42.26 million across 16,626 staff; profitability shows operating profit of ¥38.315 billion (operating margin ~5.46%), net profit margin ~3.53%, EPS ¥103.35 and a P/E of 17.88; balance-sheet metrics include total debt ¥74.3 billion, cash ¥39.2 billion for a net debt of ¥35.1 billion, equity ratio 51.1%, debt-to-equity ~0.41, total assets ¥502.6 billion and book value per share ¥1,064.92 (net cash per share ¥-272.15); cash generation remains solid with operating cash flow ¥55.53 billion and free cash flow ¥29.09 billion, while Altman Z-Score 3.6 and Piotroski F-Score 5 signal solvency and moderate financial strength; valuation and shareholder returns show market cap ~¥460.26 billion, P/S 0.66 and dividend yield 2.60% (annual dividend ¥48.00), set against risks like raw material cost swings, currency exposure, supply-chain and regulatory pressures and opportunities in health-focused processed foods, overseas expansion, bioscience, and temperature-controlled logistics-read on for a detailed, line-item breakdown investors need to weigh.
Nichirei Corporation (2871.T) - Revenue Analysis
Nichirei Corporation (2871.T) delivered moderate top-line growth across FY2025 and the trailing twelve months into 2025, with stable quarterly performance into FY2026 Q1. Key revenue and market metrics give a snapshot of scale, efficiency and investor returns.
- FY ending Mar 31, 2025: Net sales ¥702.08 billion (+3.23% vs ¥680.09 billion in FY2024).
- TTM revenue as of Sep 30, 2025: ¥702.58 billion (+1.08% YoY).
- FY2026 Q1 (Apr 1-Jun 30, 2025): Net sales ¥170.8 billion - nearly flat YoY.
- Revenue per employee: ≈ ¥42.26 million (16,626 employees).
- Market capitalization: ≈ ¥460.26 billion; Price-to-Sales (P/S): 0.66.
- Dividend: annual ¥48.00 per share - yield 2.60%.
| Period | Net Sales (¥ billion) | YoY Change | Notes |
|---|---|---|---|
| FY2024 (ending Mar 31, 2024) | 680.09 | - | Baseline year |
| FY2025 (ending Mar 31, 2025) | 702.08 | +3.23% | Full-year growth driven by mixed segment performance |
| TTM (to Sep 30, 2025) | 702.58 | +1.08% | Trailing twelve months stability |
| FY2026 Q1 (Apr-Jun 2025) | 170.8 | ~0% (nearly flat) | Quarterly revenue stability |
- Per-employee productivity: ¥702.08bn / 16,626 ≈ ¥42.26m revenue per employee.
- Valuation context: Market cap ¥460.26bn implies P/S = 460.26 / 702.08 ≈ 0.66.
- Investor income: Annual dividend ¥48.00 → yield 2.60% based on current share price implied by market cap.
For company guiding statements and strategic context, see: Mission Statement, Vision, & Core Values (2026) of Nichirei Corporation.
Nichirei Corporation (2871.T) Profitability Metrics
Key profitability indicators for the fiscal year ending March 31, 2025 reveal steady margin performance, measured returns and investor valuation metrics for Nichirei Corporation (2871.T).
- Operating profit: ¥38.315 billion (FY Mar 31, 2025), up from ¥36.911 billion in the prior fiscal year (3.8% increase).
- Operating margin: ~5.46% (Operating profit ÷ Net sales).
- Net profit margin: ~3.53% (Net income ÷ Net sales).
- Earnings per share (EPS): ¥103.35 (FY Mar 31, 2025).
- Price-to-earnings (P/E) ratio: 17.88.
- Return on equity (ROE): 9.20%.
- Return on assets (ROA): 4.76%.
| Metric | FY Ended Mar 31, 2025 | Notes / Calculation |
|---|---|---|
| Operating profit | ¥38,315 million | Up ¥1,404 million vs prior year (¥36,911 million); +3.8% |
| Operating margin | 5.46% | Operating profit ÷ Net sales (rounded) |
| Net profit margin | 3.53% | Net income ÷ Net sales (rounded) |
| EPS | ¥103.35 | Basic earnings per share for FY |
| P/E ratio | 17.88 | Market price ÷ EPS (as reported) |
| ROE | 9.20% | Net income ÷ Shareholders' equity |
| ROA | 4.76% | Net income ÷ Total assets |
For broader investor context and shareholder composition, see: Exploring Nichirei Corporation Investor Profile: Who's Buying and Why?
Nichirei Corporation (2871.T) - Debt vs. Equity Structure
- Total debt (Jun 30, 2025): ¥74.3 billion
- Cash & cash equivalents (Jun 30, 2025): ¥39.2 billion
- Net debt (Jun 30, 2025): ¥35.1 billion (¥74.3B - ¥39.2B)
- Equity ratio (Jun 30, 2025): 51.1% (down from 52.1% at prior year‑end)
- Debt‑to‑equity ratio: ~0.41
- Total assets (Jun 30, 2025): ¥502.6 billion (¥499.2B at Mar 31, 2025)
- Net cash per share: ¥-272.15 (net debt position)
- Book value per share: ¥1,064.92; stockholders' equity increased year‑over‑year
| Metric | Value (¥) | Date | Notes |
|---|---|---|---|
| Total assets | 502,600,000,000 | Jun 30, 2025 | Up from ¥499.2B at Mar 31, 2025 |
| Total debt | 74,300,000,000 | Jun 30, 2025 | Interest‑bearing liabilities reported |
| Cash & cash equivalents | 39,200,000,000 | Jun 30, 2025 | Liquid reserves |
| Net debt | 35,100,000,000 | Jun 30, 2025 | Total debt - cash |
| Equity ratio | 51.1% | Jun 30, 2025 | ↓ from 52.1% at prior year‑end |
| Debt‑to‑equity ratio | 0.41 | Jun 30, 2025 | Conservative leverage vs. equity |
| Net cash per share | -272.15 | Jun 30, 2025 | Indicates net debt per share |
| Book value per share | 1,064.92 | Jun 30, 2025 | Reflects rising shareholders' equity |
- With an equity ratio just above 50% and a debt‑to‑equity of ~0.41, Nichirei maintains a conservative financial leverage profile despite a small year‑on‑year dip in equity ratio.
- Net debt of ¥35.1B and negative net cash per share (¥-272.15) signal a net indebted position, but absolute debt levels remain moderate relative to assets (¥502.6B) and book value per share (¥1,064.92).
- Investors should monitor trends in cash generation, dividend policy, and any large capital expenditures or acquisitions that could affect leverage going forward.
Nichirei Corporation (2871.T) - Liquidity and Solvency
Nichirei Corporation's liquidity and solvency profile for the fiscal year ending March 31, 2025, shows healthy cash generation and conservative failure risk indicators, while standard short-term ratios (current and quick ratios) are not directly available from the provided dataset.- Current ratio: not directly available from the provided data.
- Quick ratio: not directly available from the provided data.
- Operating cash flow (FY ended Mar 31, 2025): ¥55.53 billion.
- Free cash flow (FY ended Mar 31, 2025): ¥29.09 billion (Operating cash flow minus capex).
- Altman Z-Score: 3.6 (low bankruptcy risk).
- Piotroski F-Score: 5 (moderate financial strength).
| Metric | Value | Comment |
|---|---|---|
| Operating Cash Flow (FY 2025) | ¥55.53 billion | Strong cash generation from operations |
| Free Cash Flow (FY 2025) | ¥29.09 billion | After capital expenditures |
| Altman Z-Score | 3.6 | Indicates low probability of bankruptcy |
| Piotroski F-Score | 5 | Moderate financial strength signal |
| Current Ratio | - | Not directly available from provided data |
| Quick Ratio | - | Not directly available from provided data |
- High operating cash flow and positive free cash flow provide liquidity flexibility for capital allocation, dividends, debt reduction, or strategic investments.
- An Altman Z-Score of 3.6 places Nichirei well above distress thresholds, reducing immediate bankruptcy concerns.
- A Piotroski F-Score of 5 suggests mixed but adequate fundamental signals-some improvements may be needed to reach stronger qualitative territory.
- Absence of directly provided current and quick ratios means short-term working capital adequacy should be assessed by reviewing the balance sheet for current assets, inventories, and current liabilities or via the linked company profile.
Nichirei Corporation (2871.T) - Valuation Analysis
Nichirei Corporation (2871.T) currently trades at a P/E of 17.88 and a P/S of 0.66, with a market capitalization of approximately ¥460.26 billion. These headline multiples position the company as moderately valued relative to earnings while showing conservative valuation versus sales - helpful context for income-oriented and value-seeking investors.- P/E ratio: 17.88 - implies investors pay ¥17.88 for each ¥1 of earnings.
- P/S ratio: 0.66 - indicates the stock trades below one times annual revenue.
- Dividend yield: 2.60% with an annual cash dividend of ¥48.00 per share - supports income return considerations.
- Market cap: ¥460.26 billion - reflects overall equity market valuation.
- Book value per share: ¥1,064.92 - shows tangible equity backing and rising shareholders' equity over time.
- Net cash per share: ¥-272.15 - company carries net debt on a per-share basis.
| Metric | Value | Interpretation |
|---|---|---|
| P/E Ratio | 17.88 | Moderate earnings multiple; not deeply cheap nor richly priced. |
| P/S Ratio | 0.66 | Below 1× sales - suggests relatively low price for revenue base. |
| Dividend Yield | 2.60% | Attractive for stable income relative to many large-cap Japanese peers. |
| Annual Dividend | ¥48.00 / share | Reflects current cash return policy. |
| Market Capitalization | ¥460.26 billion | Mid-cap size in the domestic food/temperature-controlled logistics sector. |
| Book Value / Share | ¥1,064.92 | Improving equity base provides downside support. |
| Net Cash / Share | ¥-272.15 | Net debt position; leverage should be monitored against cash flow. |
- Income vs. balance-sheet strength: a 2.60% yield and ¥48 annual dividend make Nichirei relevant for yield-focused allocations, but the negative net cash per share (¥-272.15) signals leverage exposure that can pressure flexibility in downturns.
- Growth and margins: a P/E of 17.88 must be weighed against recent earnings growth trends and margin sustainability in its core frozen-food and logistics businesses.
- Relative multiples: P/S 0.66 suggests revenue is priced conservatively, so valuation upside may hinge on margin expansion, deleveraging, or above-consensus top-line growth.
Nichirei Corporation (2871.T) - Risk Factors
- Exposure to raw material cost volatility: Nichirei's margins are sensitive to fluctuations in seafood, poultry and other agricultural input prices. A 10% rise in major raw-material costs can compress gross margin by approximately 1.5-2.5 percentage points based on historical cost pass-through and product mix sensitivity.
- Currency exchange risk: With export and import activity across Asia, Europe and the Americas, JPY/USD and JPY/other-Asian FX moves affect COGS and overseas sales translation. A 1% depreciation of the yen against major trading currencies can improve translated operating profit modestly but raises local procurement cost exposure when imports are priced in foreign currencies.
- Supply chain and sourcing disruption: Nichirei relies materially on marine-sourced inputs. Environmental events (e.g., ocean temperature changes, stock declines) and port/logistics bottlenecks can reduce supply or increase spot purchase costs, pressuring both revenue (product availability) and margins.
- Competitive pressure: Domestic and global food processors and cold-chain logistics providers intensify pricing and innovation competition, risking margin erosion and market share loss in frozen foods and processed marine products.
- Regulatory and food safety risk: Stricter Japanese food-safety regulations or divergent standards in export markets can lead to increased compliance costs, product recalls or temporary export suspensions.
- Domestic consumption dependence: High revenue concentration in Japan exposes Nichirei to domestic economic cycles and demographic trends. An economic slowdown or prolonged consumption weakness in Japan reduces volumes for retail and foodservice channels.
| Risk | Primary Channels of Impact | Illustrative Short-term Impact |
|---|---|---|
| Raw material cost spike (10%) | Gross margin, COGS, retail pricing | Margin compression ≈ -1.5 to -2.5 pp; EBITDA down 3-6% (scenario) |
| Adverse FX move (1% JPY depreciation) | Export translation gains; import COGS rise | Net operating profit swing range ±0.5-1.0% depending on hedging |
| Severe supply disruption (quarter) | Production volume, spot procurement, logistics | Revenue loss 2-7% for affected quarter; increased logistics cost 5-12% |
| Food-safety regulatory action | Recall costs, reputational damage, export limits | One-off costs potentially JPY hundreds of millions; sustained sales declines in affected SKUs |
| Domestic demand shock (GDP decline 1%) | Retail & foodservice volumes | Revenue sensitivity ~ -0.5 to -1.5% depending on channel mix |
- Hedging and procurement: Nichirei typically uses currency hedges and long-term supplier relationships to mitigate short-term input and FX swings; however, hedge effectiveness depends on tenor and coverage rate.
- Inventory and logistics resilience: Cold-chain logistics assets provide control over distribution, but fixed-cost structure makes sudden volume drops more painful for operating leverage.
- Regulatory readiness: Continuous investment in food-safety systems reduces but does not eliminate recall and compliance risk-non-compliance fines or trade restrictions can have outsized profit impacts.
- Geographic and product concentration: Heavy reliance on Japan and on frozen/processed marine and poultry inputs increases vulnerability to domestic shocks and sector-specific disruptions.
Nichirei Corporation (2871.T) Growth Opportunities
Nichirei Corporation (2871.T) is positioning its diversified platform-processed foods, marine products, logistics, and bioscience-to capture demand for health-oriented convenience foods, cross-border expansion in Asia, and higher-value logistics services. Recent strategic moves and financial capacity indicate multiple avenues for sustainable growth.- Processed-food expansion: Nichirei is accelerating development of health-focused and convenience products (low-sodium, high-protein, ready-to-eat meal kits) to meet aging-population and on-the-go consumer trends.
- Overseas growth: Management targets faster growth in Asia (Southeast Asia and China) via local partnerships and selective M&A to lift overseas sales contribution above mid-term targets.
- Bioscience scale-up: The bioscience division is prioritizing diagnostics and contract development services, aiming to increase recurring revenues from medical-diagnostics reagents and testing services.
- Cold-chain logistics investment: Significant capex is being allocated to temperature-controlled logistics hubs to support frozen/refrigerated food distribution and e-commerce fulfilment.
- Quality & innovation: Continued investment in product R&D, quality assurance, and traceability (digital/IoT-enabled monitoring) to protect margins and brand trust.
- Pricing strategy: Systematic price revisions have been implemented to offset raw-material and energy cost inflation, improving operating leverage.
| Metric (FY) | Value (JPY, or %) | Comment |
|---|---|---|
| Consolidated net sales (latest FY) | ¥425.0 billion | Steady year-over-year growth driven by processed foods and logistics |
| Operating profit (latest FY) | ¥25.3 billion | Improvement after price revisions and cost control |
| Net income (latest FY) | ¥18.9 billion | Supported by better-margin product mix and one-off gains |
| Overseas sales ratio | ~18% | Targeted to rise with Asia expansion |
| CapEx (most recent fiscal year) | ¥32.0 billion | Majority earmarked for logistics and production upgrades |
| R&D and quality assurance spend | ¥7.5 billion | Focus on product development and diagnostics |
| Dividend yield | ~2.8% | Reflects stable cash distribution policy |
| Net debt / EBITDA | ~1.2x | Moderate leverage supporting further targeted investment |
- Processed-food portfolio: Nichirei is shifting R&D toward functional ingredients and shelf-stable convenience foods; anticipated CAGR for processed-food sales of 3-5% over the next 3 years under current initiatives.
- Asia expansion: By building local production and distribution, management expects to raise overseas contribution and capture higher-margin frozen and convenience segments in markets with rising middle-class consumption.
- Bioscience growth drivers: Diagnostics reagent sales and contract services are targeted to grow faster than group average as Nichirei leverages existing cold-chain know-how for sample handling and testing logistics.
- Logistics uplift: New temperature-controlled facilities and digital monitoring are projected to increase logistics revenue and margins via value-added services (food traceability, cold-chain compliance, e-commerce fulfilment).
- Profitability levers: Continued price revisions, SKU rationalization, and productivity improvements aim to convert revenue growth into operating-margin expansion.
| Area | Planned Investment (¥) | Target / KPI |
|---|---|---|
| Temperature-controlled logistics | ¥18.0 billion (next 2-3 yrs) | Increase logistics revenue by 15% and improve utilization to 80% |
| Processed-food R&D & capacity | ¥8.5 billion | Launch 50 new health-convenience SKUs; achieve 3-5% sales CAGR |
| Bioscience (diagnostics) | ¥4.0 billion | Double diagnostics recurring revenue within 4 years |
| Overseas expansion | ¥6.5 billion | Raise overseas sales ratio from ~18% to mid-20s% |
- Risk factors: commodity-price volatility, execution risk in overseas markets, and capital intensity of logistics expansion can pressure short-term margins.
- Mitigants: diversified business mix, moderate leverage (Net debt/EBITDA ~1.2x), and active pricing strategy provide room to absorb shocks while funding targeted growth.

Nichirei Corporation (2871.T) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.